Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · IEX Real-Time Price · USD
2.740
+0.310 (12.76%)
At close: Mar 28, 2024, 4:00 PM
2.870
+0.130 (4.74%)
After-hours: Mar 28, 2024, 7:37 PM EDT

Revelation Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020
Net Income
-0.12-10.83-11.99-1.63
Depreciation & Amortization
0.030.040.070
Share-Based Compensation
0.160.30.470.03
Other Operating Activities
-7.35-0.730.360.18
Operating Cash Flow
-7.29-11.22-11.09-1.42
Capital Expenditures
00-0.130
Investing Cash Flow
00-0.130
Share Issuance / Repurchase
14.0315.980.65.51
Debt Issued / Paid
0-0.800
Other Financing Activities
-00.017.40.4
Financing Cash Flow
14.0315.285.91
Net Cash Flow
6.743.98-3.224.49
Free Cash Flow
-7.29-11.22-11.22-1.42
Free Cash Flow Per Share
-31.87-154.57-1193.74-618.88
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).